Nanosphere Enters Into $30 Million Common Stock Purchase Agreement With Aspire Capital
March 18, 2014 17:00 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., March 18, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced it has entered into a Common...
Nanosphere to Present at the 26th Annual ROTH Conference
March 06, 2014 12:00 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., March 6, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that an overview of the...
Nanosphere to Host Investor Day on March 20th in New York
March 03, 2014 08:00 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., March 3, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it will host an Investor...
![Nanosphere, Inc. Logo](/news-release/logo/213906/0/213906.jpg?lastModified=12%2F09%2F2016%2023%3A01%3A53&size=2)
Nanosphere to Release Q4 and Full Year 2012 Results and Hold Investor Call on Wednesday, February 13
February 05, 2013 10:07 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Feb. 5, 2013 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, will report its results...
![Nanosphere, Inc. Logo](/news-release/logo/213906/0/213906.jpg?lastModified=12%2F09%2F2016%2023%3A01%3A53&size=2)
Nanosphere Receives FDA Clearance for C. difficile Test
December 10, 2012 15:26 ET
|
Nanosphere, Inc.
Comprehensive sample-to-result test detects potentially deadly C. difficile and identifies 027 hypervirulent strain
Expands menu of infectious disease tests on Verigene®...
![Nanosphere, Inc. Logo](/news-release/logo/213906/0/213906.jpg?lastModified=12%2F09%2F2016%2023%3A01%3A53&size=2)
Nanosphere to Present at Canaccord Genuity Medical Technology & Diagnostics Forum
November 29, 2012 09:47 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Nov. 29, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced that William...
![Nanosphere, Inc. Logo](/news-release/logo/213906/0/213906.jpg?lastModified=12%2F09%2F2016%2023%3A01%3A53&size=2)
Nanosphere to Present at Piper Jaffray 24th Annual Healthcare Conference
November 21, 2012 10:51 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Nov. 21, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced that William...
![Nanosphere, Inc. Logo](/news-release/logo/213906/0/213906.jpg?lastModified=12%2F09%2F2016%2023%3A01%3A53&size=2)
Nanosphere Receives FDA Clearance to Market Test for Detection of CYP2C19 Mutations Affecting Drug Metabolism
November 13, 2012 07:45 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Nov. 13, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced today the US...
![Nanosphere, Inc. Logo](/news-release/logo/213906/0/213906.jpg?lastModified=12%2F09%2F2016%2023%3A01%3A53&size=2)
Nanosphere Announces Third Quarter 2012 Results
November 07, 2012 16:01 ET
|
Nanosphere, Inc.
50 new VerigeneSP system placements double over prior quarter
C. difficile assay filed with FDA
FDA categorizes blood stream gram-positive test as CLIA moderate complexity
NORTHBROOK,...
![Nanosphere, Inc. Logo](/news-release/logo/213906/0/213906.jpg?lastModified=12%2F09%2F2016%2023%3A01%3A53&size=2)
Nanosphere to Present at Lazard Capital Markets and Stephens Inc. Investor Conferences
November 06, 2012 09:29 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Nov. 6, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced that William...